XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 12,441,509 $ 6,961,669 $ 33,594,761 $ 25,160,437
General and administrative 3,696,067 2,588,701 9,944,487 11,535,868
Loss from operations (16,137,576) (9,550,370) (43,539,248) (36,696,305)
Other income (expense):        
Interest income 1,503,845 1,902,242 4,951,949 5,463,928
Interest expense (479,252) (538,743) (1,455,378) (1,557,171)
Total other income (expense), net 1,024,593 1,363,499 3,496,571 3,906,757
Net loss $ (15,112,983) $ (8,186,871) $ (40,042,677) $ (32,789,548)
Net loss per share - basic $ (0.25) $ (0.14) $ (0.67) $ (0.56)
Net loss per share - diluted $ (0.25) $ (0.14) $ (0.67) $ (0.56)
Weighted average common shares outstanding - basic 59,530,113 58,990,189 59,453,312 58,858,631
Weighted average common shares outstanding - diluted 59,530,113 58,990,189 59,453,312 58,858,631